Close Menu

NEW YORK – Agios Pharmaceuticals said on Monday that it has partnered with PerkinElmer Genomics on a genetic testing program for patients with suspected hereditary anemias.

Testing will be performed using a next-generation sequencing-based panel comprising more than 50 genes and disorders known to cause hereditary anemias, such as pyruvate kinase deficiency.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.